Theralase Technologies Inc.
TLT.V
TSX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -5.24% | -5.23% | -9.98% | -10.48% | -9.27% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -5.24% | -5.23% | -9.98% | -10.48% | -9.27% |
| Cost of Revenue | -7.20% | -2.61% | 0.23% | -1.78% | -4.17% |
| Gross Profit | -3.46% | -7.55% | -18.61% | -17.46% | -13.44% |
| SG&A Expenses | -5.34% | 7.10% | 11.60% | 26.63% | 32.03% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -7.41% | -3.67% | -9.80% | -11.43% | -14.66% |
| Operating Income | 7.93% | 3.32% | 9.77% | 11.65% | 15.81% |
| Income Before Tax | 8.15% | 3.80% | 10.35% | 12.28% | 16.30% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 8.15% | 3.80% | 10.35% | 12.28% | 16.30% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 8.15% | 3.80% | 10.35% | 12.28% | 16.30% |
| EBIT | 7.93% | 3.32% | 9.77% | 11.65% | 15.81% |
| EBITDA | 7.88% | 3.01% | 9.58% | 11.18% | 15.53% |
| EPS Basic | 14.84% | 9.80% | 15.29% | 16.85% | 20.92% |
| Normalized Basic EPS | 15.46% | 10.42% | 15.89% | 16.96% | 21.14% |
| EPS Diluted | 14.84% | 9.80% | 15.29% | 16.85% | 20.92% |
| Normalized Diluted EPS | 15.46% | 10.42% | 15.89% | 16.96% | 21.14% |
| Average Basic Shares Outstanding | 8.57% | 6.64% | 6.17% | 5.87% | 5.86% |
| Average Diluted Shares Outstanding | 8.57% | 6.64% | 6.17% | 5.87% | 5.86% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
